Relmada names clinicians, researchers to advisory roles
Relmada Therapeutics (OTCQB:RLMD) has appointed several leading clinicians and researchers, with expertise in opioid receptors, addiction, psychiatry, neuropathic pain, and clinical trial methodology,...
View ArticleClerio Vision developing non-invasive laser vision correction
Closely-held Clerio Vision hopes to begin proof-of-concept studies next year of a non-invasive, incision-less and tissue sparing vision correction laser technology that modifies the refractive index of...
View Article
More Pages to Explore .....